Well Health Technologies Stock Current Liabilities
WELL Stock | CAD 5.86 0.31 5.59% |
WELL Health Technologies fundamentals help investors to digest information that contributes to WELL Health's financial success or failures. It also enables traders to predict the movement of WELL Stock. The fundamental analysis module provides a way to measure WELL Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to WELL Health stock.
As of the 2nd of December 2024, Total Current Liabilities is likely to grow to about 160.6 M. Also, Non Current Liabilities Total is likely to grow to about 430.7 M. WELL | Current Liabilities |
WELL Health Technologies Company Current Liabilities Analysis
WELL Health's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
WELL Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for WELL Health is extremely important. It helps to project a fair market value of WELL Stock properly, considering its historical fundamentals such as Current Liabilities. Since WELL Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of WELL Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of WELL Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
WELL Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, WELL Health Technologies has a Current Liabilities of 0.0. This is 100.0% lower than that of the Health Care Providers & Services sector and about the same as Health Care (which currently averages 0.0) industry. The current liabilities for all Canada stocks is 100.0% higher than that of the company.
WELL Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of WELL Health from analyzing WELL Health's financial statements. These drivers represent accounts that assess WELL Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of WELL Health's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 151.2M | 1.1B | 937.3M | 626.8M | 910.7M | 956.2M | |
Enterprise Value | 154.7M | 1.0B | 1.3B | 936.3M | 1.3B | 1.4B |
WELL Fundamentals
Return On Equity | 0.11 | ||||
Return On Asset | 0.0245 | ||||
Profit Margin | 0.08 % | ||||
Operating Margin | 0.07 % | ||||
Current Valuation | 1.79 B | ||||
Shares Outstanding | 248.93 M | ||||
Shares Owned By Insiders | 21.32 % | ||||
Shares Owned By Institutions | 6.12 % | ||||
Number Of Shares Shorted | 1.29 M | ||||
Price To Book | 1.72 X | ||||
Price To Sales | 1.52 X | ||||
Revenue | 776.05 M | ||||
Gross Profit | 303.29 M | ||||
EBITDA | 101.88 M | ||||
Net Income | 82 K | ||||
Cash And Equivalents | 48.91 M | ||||
Cash Per Share | 0.25 X | ||||
Total Debt | 426.28 M | ||||
Debt To Equity | 0.48 % | ||||
Current Ratio | 1.14 X | ||||
Book Value Per Share | 3.40 X | ||||
Cash Flow From Operations | 62.59 M | ||||
Short Ratio | 1.25 X | ||||
Earnings Per Share | 0.31 X | ||||
Price To Earnings To Growth | (1.32) X | ||||
Target Price | 7.68 | ||||
Beta | 1.18 | ||||
Market Capitalization | 1.46 B | ||||
Total Asset | 1.41 B | ||||
Retained Earnings | (63.58 M) | ||||
Working Capital | 23.44 M | ||||
Net Asset | 1.41 B |
About WELL Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze WELL Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WELL Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WELL Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in WELL Stock
WELL Health financial ratios help investors to determine whether WELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WELL with respect to the benefits of owning WELL Health security.